Fairway Asset Management

Positrigo AG is a Zurich-based company specializing in the development, manufacturing, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on providing functional imaging solutions that facilitate the early detection of neurodegenerative diseases, particularly Alzheimer's disease, as well as other conditions like Lewy body dementia, vascular dementia, and frontotemporal dementia. The company's PET scanners are designed to be accessible and affordable, enabling healthcare professionals to diagnose and monitor treatment effectively, while also contributing to the advancement of new therapies in the field of neurology.